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Abstract
In cells, RNAs likely adopt numerous intermediate conformations prior to formation of functional 
RNA-protein complexes. We used single-nucleotide resolution SHAPE to probe the structure of E. 
coli 16S ribosomal RNA (rRNA) in healthy growing bacteria. SHAPE-directed modeling indicated 
that the predominant steady-state RNA conformational ensemble in dividing cells had a base 
paired structure different from that expected based on comparative sequence analysis and high-
resolution studies of the 30S ribosomal subunit. We identified the major cause of these differences 
by stopping ongoing in-cell transcription (in essence, an in-cell RNA structure pulse-chase 
experiment) which caused the RNA to chase into a structure that closely resembled the expected 
one. Most helices that formed alternate RNA conformations under growth conditions interact 
directly with tertiary-binding ribosomal proteins and form a C-shape that surrounds the mRNA 
channel and decoding site. These in-cell experiments lead to a model in which ribosome assembly 
factors function as molecular struts to pre-organize this intermediate and emphasize that the final 




After transcription, RNA molecules undergo complex processing, folding, and protein and 
ligand association reactions essential for cellular function. The conformations of many 
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approaches; however, RNA folding and RNA-protein assembly reactions have only recently 
been visualized at high resolution in living cells.1–4 Under optimal growth conditions, cells 
spend significant energy to assemble the ribosomes that synthesize the proteome necessary 
for all phases of cellular function.5 In bacteria, the ribosome is composed of 30S and 50S 
subunits that ultimately assemble to form the 70S ribosome. The 1542-nucleotide 16S 
ribosomal RNA (rRNA) of E. coli is the largest component of the 30S subunit and comprises 
a large fraction of the total RNA in a bacterium.6
Biogenesis of the 30S ribosomal subunit involves a complex series of interrelated events: 
The precursor 16S rRNA molecule is transcribed then processed via endonucleolytic 
cleavage to the mature full-length form and covalently modified at specific, conserved sites. 
The RNA folds and ribosomal proteins bind in a semi-ordered fashion to form the 30S 
subunit. Upon association with initiation factors and the 50S subunit, 30S subunits become 
part of the 70S ribosome. This large complex associates with elongation factors, tRNA, and 
mRNA to carry out protein synthesis. Ultimately, ribosomal subunits are disassembled and 
constituent RNAs are degraded.6–9
Significant strides have been made toward understanding ribosome assembly through in 
vitro experiments,10–12 and recent work has explored the protein and RNA compositions of 
assembly intermediates in cells.2–4 In vitro and in-cell assembly mechanisms differ. First, in 
vitro assembly experiments are generally performed using full-length ribosomal RNA, 
whereas cellular assembly occurs co-transcriptionally. Second, the rates of 30S assembly 
and cell-free translation in vitro are dramatically slower than the rates in vivo.6,13 Third, 30S 
assembly in vitro requires a sharp temperature increase6 and specialized buffer systems.14 
Despite their importance, the relationships between in-cell RNA conformation and extensive 
characterizations in vitro are not well understood.
Selective 2′-hydroxyl acylation analyzed by primer extension (SHAPE) quantitatively 
measures local nucleotide flexibility at all four nucleotides in an RNA.15,16 The most useful 
and structurally informative SHAPE reagent developed to date is 1M7. The reactivity of 
1M7 is strongly correlated with model-free measures of molecular motion17 and 
incorporation of 1M7 reactivities as a pseudo-free energy term in RNA structure prediction 
algorithms yields accurate RNA secondary structure models.18,19 1M7 is a small, slightly 
hydrophobic molecule that readily crosses cell membranes.1,20 SHAPE reagents are initially 
suspended in a non-reactive organic solvent, such as DMSO, to prevent premature 
hydrolysis.21 Bacterial cells grown in 2 to 4% DMSO achieve growth rates and final cell 
densities comparable to cells grown in the absence of DMSO.1 Thus, SHAPE can be 
performed in vivo without impacting bacterial cell viability.
In this work, we use SHAPE to visualize the structure of 16S rRNA in ribosome assembly 
intermediates in healthy growing bacterial cells. We discovered that widespread 
conformational changes occur in the RNA during late stages of ribosome assembly. Together 
with other recent work, in-cell SHAPE analysis supports a simple "molecular strut" model 
for how late-acting ribosome assembly factors facilitate 30S assembly.
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 1M7 lifetime in growth media
Hydrolysis of 1M7 was followed by addition of 2.0 mM 1M7 in 100 µL DMSO to 900 µL 
Luria broth (LB) (pH 6.5 or 7.0) pre-equilibrated at 37 °C in a cuvette. Pseudo-first-order 
rate constants were obtained by monitoring the absorbance of the hydrolysis product (2-
methylamino-4-nitrobenzoate) at 430 nm.1,21
 SHAPE analysis of 16S rRNA structure in vivo
DH5α cells (500 mL) were grown in LB to an OD600 of ~0.6 starting from 5 mL of an 
overnight culture. RNA modification was initiated by adding an aliquot of cell culture (14 
mL) to 433 µL of 167 mM 1M7 in DMSO (5 mM 1M7 final). The control cell sample was 
treated with neat DMSO (3% vol/vol). Samples were allowed to react with shaking for 5 min 
at 37 °C. An untreated aliquot of cell culture was obtained for dideoxy sequencing. Cells 
were collected by centrifugation (4,000 ×g for 20 min, 4 °C). Cell pellets were resuspended 
in 200 µL TE buffer containing 30 mg/mL lysozyme and incubated on ice for 5 min. RNA 
was purified by affinity chromatography (RNeasy Mini column; Qiagen). RNA 
concentrations were determined by absorbance at 260 nm. For all samples, the purified RNA 
contained total cellular RNA. For experiments in which transcription was inhibited, cell 
growth was initiated as above and, at an OD600 of ~0.5, 50 mL of cells were added to either 
5.55 mL rifampicin in H2O (final concentration 18.75 µg/mL) or 5.55 mL H2O. Cells were 
incubated with vigorous shaking for 20 min and in-cell SHAPE was performed as described 
above.
 Primer extension
Five primer sets were used to analyze the 16S rRNA with the 3′ positions of the primers 
complementary to 16S rRNA positions 323, 559, 947, 1112, and 1492.16 We were ultimately 
able to examine 94% of the nucleotides in the 16S rRNA, but did not analyze ~65 nts at the 
very 3' end of the RNA. Primer extension was performed as described22 except that modified 
total cellular RNA (2.1 µg) and primer (2 pmol) were mixed and diluted to 13 µL with water 
prior to the primer-annealing step. Dideoxy sequencing ladders were produced using 
unlabeled, unmodified total cellular RNA (in 12 µL) and 1 µL 2′,3′-dideoxycytidine (5 mM) 
triphosphate. cDNA fragments were separated by capillary electrophoresis using an Applied 
Biosystems 3500 capillary electrophoresis instrument.
 Data analysis
Capillary electrophoresis traces were processed using QuShape.23 Datasets were normalized 
using model-free statistics to a scale of 0 to ~2. Nucleotides with normalized SHAPE 
reactivities 0–0.4, 0.4–0.85, and >0.85 correspond to unreactive, moderately reactive, and 
highly reactive positions, respectively. Each experiment was performed at least twice, and 
data were reproducible.
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 RNA structure modeling
Alternative secondary structure models were generated using RNAstructure24 in conjunction 
with SHAPE pseudo-free energy change constraints.18,19
 Solvent accessibility
Solvent accessibility surface area (SASA) of the 2′-hydroxyl group was calculated with 
NACCESS 2.1.1 (http://www.bioinf.machester.ac.uk/naccess/) using a probe size of 2.8 Å 
and the atomic coordinates from 3i1m (30S) and 3i1n (50S).25 Nucleotides were taken to be 
surface nucleotides if the SASA was greater than 5 Å2. Nucleotides at the subunit interface 
of the 30S were defined as those that became inaccessible when the 50S subunit was added. 
Nucleotides in the 16S rRNA in direct contact with proteins were defined as those that 
became inaccessible when 30S proteins were added. Nucleotides in the 16S rRNA involved 
in RNA-RNA domain interactions were defined as nucleotides that became inaccessible 
when the other domains were included. Domains of the 16S rRNA were defined as: 5′, nts 
1–566; central, nts 567–912; 3′-major, nts 913–1396; and 3′-minor, nts 1397–1542.
 Results
 Cell viability, time-scale, and quality of in vivo SHAPE
The hydrolysis half-life of 1M7 in standard growth media during mid-log phase of cell 
growth is 24 sec (Fig. 1A, B); under these conditions, the SHAPE reaction will be complete 
in approximately 2 minutes (5 hydrolysis half-lives). This is an ideal timescale because the 
1M7 reagent is sufficiently stable to afford straightforward experimental use but makes rapid 
and facile in-cell structure analysis possible.
In vivo SHAPE was performed by growing E. coli cell cultures to mid-log phase (OD600 = 
0.6) and adding an aliquot of cells directly to 1M7 in DMSO (3% vol/vol, final). After 2 
minutes, cells were pelleted and lysed, the cellular debris and proteins removed, and total E. 
coli cellular RNA purified. Sites of in vivo SHAPE adduct formation in the 1542-nucleotide 
16S rRNA were detected by primer extension and resolved by capillary gel electrophoresis 
using five sets of DNA primers.16 Quantitative SHAPE reactivity data were obtained for 
1,450 nucleotides (94%) of the 16S rRNA. The quality of the single-nucleotide resolution 
SHAPE data was very high as evidenced by a low level of background in the no-reagent 
control reaction and by the perfect agreement between the RNA-based sequencing reaction 
and the known 16S rRNA sequence (Fig. 1C,D). The 1M7 SHAPE reagent thus readily 
crossed the complex double membrane of the Gram-negative E. coli bacterial cell to yield an 
~2-minute-resolution snapshot of the conformationally dynamics of almost all nucleotides in 
the 16S RNA.
 16S rRNA structure in rapidly growing cells differs from the accepted structure
When the in vivo SHAPE reactivities were superimposed on the accepted secondary 
structure model26,27 of the E. coli 16S rRNA, the majority of reactivities showed excellent 
agreement with the accepted secondary structure (Fig. 2, grey highlights). In general, single-
stranded nucleotides in the accepted structure showed medium or high reactivities, whereas 
most nucleotides expected to be base paired were unreactive by SHAPE.
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A small number of nucleotides predicted to be non-base paired in the accepted secondary 
structure model had low SHAPE reactivities. Since SHAPE measures molecular motion,17 it 
is likely these nucleotides are involved in higher-order tertiary contacts or interactions with 
proteins. These unreactive nucleotides in the 16S rRNA were examined in context of the 
three-dimensional structure of the 70S ribosome.25 Almost all of these unreactive 
nucleotides are indeed involved in RNA tertiary interactions or are located within or near 
protein binding sites (Fig. 2, black stars). For example, the unreactive nucleotides 132–135 
and 260–265 interact via direct RNA-RNA contacts. Similarly, the unreactive loop 
nucleotides at positions 260–265, 321–323, 326–330 are all located near the protein-binding 
site for the S20 protein, one of the first proteins to bind during 30S assembly.6
Approximately 10% of 16S rRNA nucleotides predicted to be constrained by base pairing in 
the accepted structure exhibited medium or high SHAPE reactivities. These nucleotides 
were not spread uniformly throughout the RNA but were clustered in a small number of 
helices, most of which were located in irregular or multi-helix junctions (Fig. 2, magenta 
and cyan boxes). Of the 14 helices in which these nucleotides are located, ten have reactive 
nucleotides on both strands of the helix (H2, H3, H16/H17, H26b, H28, H31, H36, H41, and 
H44), making it unlikely that these helices are stably formed in the steady-state 16S rRNA 
structure in vivo (Fig. 2, magenta boxes). In four of the 14 regions (H12, H33b, H34, and 
H38), SHAPE-reactive nucleotides are adjacent to unreactive nucleotides that are single-
stranded in the accepted secondary structure. In these regions, the predominant pattern of 
base pairing in vivo likely differs from that in the accepted secondary structure model.
We identified plausible alternative structures in these discordant regions by using the in-cell 
SHAPE data to model local RNA folding18,19 (Fig. 2, cyan boxes, alternate base pairs shown 
with dark blue lines). For example, in helix 34 in the accepted secondary structure, 
nucleotides 1055 and 1200–1202 are bulged; these nucleotides were expected to be reactive 
to SHAPE reagent but instead are unreactive in vivo. In contrast, nucleotides 1053, 1204, 
and 1205 are base paired in the accepted structure, but are reactive in vivo. In the alternate 
SHAPE-directed structure model, nucleotides 1200–1202 pair with nucleotides 1057–1055 
(Fig. 2, dark blue lines in H34), and nucleotides 1053, 1054, and 1203–1205 are bulged. In-
cell SHAPE also suggests local base pairing rearrangements relative to the accepted 
structure in helices H12, H33, and H38 (Fig. 2, cyan boxes). In each case, the alternative 
base-pairing patterns are more consistent with the SHAPE-measured in vivo nucleotide 
dynamics than is the accepted structural model.
At mid-log phase, E. coli cells are dividing actively, and levels of ribosomal RNA synthesis 
are high. Ribosome components, including the rRNA, are present at multiple stages of 
biogenesis. The experimental SHAPE reactivities measured in cells grown to mid-log phase 
may therefore reflect reactivities of 16S rRNA molecules that have not been fully assembled 
into 30S subunits. Differences observed between the SHAPE-directed model and the 
accepted secondary structure likely reflect the fact that the snapshot of the 16S rRNA taken 
by SHAPE in rapidly growing cells reflects the conformations of intermediates in ribosome 
assembly.
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 Halting transcription converts 16S rRNA structure to roughly the accepted one
Halting transcription will stop production of new 16S rRNA transcripts and should allow 
the16S rRNA to be incorporated into 30S subunits and 70S ribosomes. To evaluate the effect 
of transcription inhibition on 16S rRNA structure, we performed a kinetic "chase" 
experiment at nucleotide resolution in vivo. We added the antibiotic rifampicin, which 
inhibits transcription,28 to cells at mid-log phase (OD600 = 0.5). Rifampicin inhibits 
transcription by binding to the bacterial RNA polymerase, but does not bind to the ribosome. 
Changes in SHAPE reactivity of the 16S rRNA will thus reflect the effects of arrested 
transcription rather than direct effects on ribosomal RNA structure. Rifampicin halts 
transcription initiation within 70 seconds of addition. It requires approximately 2.2 minutes 
to transcribe an rRNA operon29 and an additional ~2 minutes for the 16S rRNAs to be 
processed and incorporated into 30S subunits.13 When cells were incubated with rifampicin 
for either 20 or 60 minutes prior modification with 1M7, SHAPE reactivity profiles were 
essentially identical. Therefore, we analyzed SHAPE reactivity profiles for the 16S rRNA 20 
minutes after rifampicin addition (~5 half lives for rRNA synthesis and assembly).
During rRNA maturation, RNase III cleaves the primary 16S rRNA transcript to generate a 
form of the 16S rRNA precursor (the 17S rRNA) that contains an additional 115 and 33 
nucleotides at the 5′ and 3′ ends, respectively, relative to the mature form.6 The amount of 
17S precursor relative to mature 16S rRNA was quantified by primer extension analysis 
across the 5′ terminus of the mature rRNA.30 In log-phase cells without addition of 
antibiotic, 16% of the total 16S rRNA contained an unprocessed 5′ end. After incubation 
with rifampicin for 20 minutes, the percentage of RNA with an unprocessed 5′ end 
decreased to 2.5%. Thus, mid-log phase E. coli cells contain a significant fraction of 
incompletely processed 16S rRNA, and rifampicin addition promotes nearly complete 
conversion to the fully processed rRNA.
After inhibition of transcription, SHAPE reactivities for many nucleotides in the 16S rRNA 
differed from those measured in the absence of rifampicin. Of the nucleotides with moderate 
or high reactivity in the absence of rifampicin (defined as ≥ 0.4), more than half (273/509) 
exhibited a significant decrease (greater than 0.3 SHAPE units) in reactivity upon rifampicin 
addition (Fig. 3, highlighted in blue). Overall, the 16S rRNA becomes much more structured 
after transcription arrest. Of the 273 nucleotides that decreased by more than 0.3 SHAPE 
reactivity units upon inhibition of transcription, 58 (~20%) changed in a way that resolved 
discrepancies between the SHAPE-directed model and accepted secondary structure models 
(Fig. 3, magenta and cyan boxes). For example, the mean in vivo SHAPE reactivity of 
nucleotides in the H33b helix decreased from 0.5 to 0.2 when transcription was halted, 
consistent with formation of the base pairs observed in the accepted secondary structure. 
Transcription arrest ultimately yielded an in-cell SHAPE profile that was ~99% consistent 
with the accepted secondary structure. A small number (17 or ~1%) of 16S rRNA 
nucleotides increased by more than 0.3 SHAPE reactivity units upon rifampicin addition 
(Fig. 3, circled in orange). All of these nucleotides are in single-stranded or weakly paired 
regions, suggestive of changes in loop dynamics that accompanied formation of higher 
levels of overall structure in the 16S rRNA.16,17
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 Strong 5' to 3' polarity in rifampicin-induced changes in 16S rRNA structure
Roughly 20 times more nucleotides showed decreases in SHAPE reactivity versus increases 
upon rifampicin addition. There is a clear 5′ to 3′ polarity in the differences between SHAPE 
reactivity in the absence and the presence of rifampicin (Fig. 4A). As averaged over 51-nt 
windows, relatively few nucleotides in the 5' domain differed in SHAPE reactivity when 
reactivity profiles in the absence and presence of rifampicin are compared, but 30 to 35% of 
the nucleotides in the 3' major and 3' minor domains decreased significantly in reactivity in 
the absence of transcription. In addition, local peaks in the number of reactivity differences 
occur precisely at the junctions between domains of the 16S rRNA (Fig. 4A, vertical dashed 
lines). The positions that become less reactive to 1M7 in cells upon rifampicin treatment are 
superimposed on the three-dimensional structure of the 16S rRNA (Fig. 4B). The observed 
polarity in structural differences is consistent with an ordered ribosomal assembly process 
and with co-transcriptional folding and assembly into 30S subunits.
We next examined the role that higher-order interactions play in the in-cell assembly process 
by identifying nucleotides accessible to solvent in the context of each folded domain. 
SHAPE reactivities are not fundamentally governed by solvent or molecular accessibility: 
they are instead determined by local nucleotide dynamics.16,17 However, we used solvent 
accessibility as a metric to identify nucleotides located on the exterior of each domain in the 
16S rRNA. We then identified the nucleotides that differed in reactivity in the presence and 
absence of rifampicin that became protected from solvent in the context of the crystal 
structure of the 70S ribosome and assigned these as predominately reflecting inter-domain 
RNA-RNA interactions (Fig. 5A, green spheres, 50 total), RNA-protein interactions (yellow 
spheres, 47 total), and interactions with the 50S subunit (purple spheres, 7 total). Most 
nucleotides whose protection likely reflects direct RNA-RNA domain interactions are 
located in the central domain and make contact with the 3′ minor domain (Fig. 5A, green 
spheres). Other nucleotides that differed in reactivity in the presence and absence of 
rifampicin are located at a compact interface between the 5' and 3' domains.
Almost half of the nucleotides protected upon rifampicin addition are in direct contact with 
ribosomal proteins and most of these primarily reflect RNA-protein interactions that occur in 
the 3' major domain (Fig. 5A, yellow spheres). Thus, protein association with the 3' domain 
appears to be a major rate-determining step for 30S subunit assembly in cells. We identified 
the small subunit proteins that are in direct contact with the 14 helices that undergo large 
conformational changes upon rifampicin addition (Figs. 2 and 3). Eight of the 20 small 
subunit proteins interact with the fourteen helices (Fig. 5C, circles). Strikingly, six of the 
eight proteins are those previously identified as tertiary-binding proteins31 (Fig. 5C, 
emphasized with yellow circles). In addition, S9, although not formally characterized as a 
tertiary-binding protein, participates in a network involving four of the tertiary-binding 
proteins (Fig. 5C, also emphasized with a yellow circle). The one additional protein-RNA 
interaction, involving S4 and the H16/17 RNA helix, undergoes a late conformational 
change distinct from the multiple changes involving the tertiary-binding proteins (Fig. 5C, 
green circle). Overall, the in-cell data imply that binding by the tertiary proteins is 
accompanied by widespread and previously unobserved structural changes in the 16S rRNA.
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 SHAPE reveals intermediates in in-cell ribosome assembly
The 1M7 SHAPE reagent readily traverses the complex cell wall of the E. coli bacterium to 
modify RNA in a structure-selective manner. We used this reagent to obtain snapshots of the 
structure of 16S rRNA in bacteria at the mid-log phase of growth, when much of the rRNA 
has clearly not been fully assembled into ribosomes, and in the presence of a transcription 
inhibitor when most of the 16S rRNA has been incorporated into mature ribosomes. 1M7 
elegantly balances the needs of experimental ease of use with high accuracy in probing 
nucleotide-resolution RNA dynamics.1,19,21
All experiments probing in-cell states likely report on complex ensembles of steady-state 
intermediates, including diverse RNA folding states and RNA-protein complexes comprised 
of heterogeneous complements of proteins. We found that 17% of 16S rRNA precursor 
transcripts have an incompletely processed 5' end and, thus, the “snapshot” taken using 
SHAPE in rapidly growing cells reflects 16S rRNA that is in various stages of assembly 
(Fig. 2). Our direct measurement of unprocessed RNA indicates a much larger fraction of 
30S subunits are incompletely assembled in rapidly growing cells than generally 
assumed.13,32 Our results, although surprising, are consistent with recent studies showing 
high levels of ribosomal particles with incomplete complements of ribosomal proteins3 and 
with studies indicating that RNA is generally less structured in dividing cells.33
Critically, this work reveals a broad mechanism underlying the observation of increased 
RNA dynamics in cells. Upon inhibition of transcription using rifampicin, which results in 
conditions where the vast majority of 16S rRNA is incorporated into 30S subunits, SHAPE 
reactivities were ~99% consistent with the accepted secondary26 and tertiary25 structure 
(Fig. 3). Thus, many differences observed in growing cells reflect an on-going 
ribonucleoprotein assembly process.
There is a strong 5’ to 3’ polarity in the extent to which nucleotide reactivities changed in 
the absence compared to the presence of rifampicin (Fig. 4). This is consistent with co-
transcriptional folding and assembly into 30S subunits. In addition, domain junctions were 
punctuated by significant differences in nucleotide reactivity in the presence and absence of 
rifampicin, consistent with formation of local inter-domain interactions. In-cell SHAPE, 
coupled with chasing complex steady-state RNA and ribonucleoprotein ensembles into more 
structurally mature forms by transcription inhibition, is a broadly useful approach for 
defining RNA-protein assembly intermediates and inter-domain junctions in 
ribonucleoprotein complexes.
 Domain-specific assembly features
For the 16S ribosomal RNA studied here, the differences in nucleotide reactivities in the 
presence and absence of rifampicin reflect distinct underlying physical processes in each 
ribosomal domain. In the 5' domain, all nucleotides whose reactivities were responsive to 
rifampicin showed decreases in reactivity. Moreover, over 80% (44/54) of these nucleotides 
are located in RNA elements that form intra-domain interactions (Figs 4B and 5A, 5’ 
domain panels). Thus, the 5' domain undergoes internal tightening and consolidation in 
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structure in mature ribosomes compared to less mature forms. In contrast, for the central 
domain, roughly 65% (31/48) of the nucleotides that decreased in reactivity are involved in 
inter-domain or RNA-protein interactions, with the majority reflecting RNA-RNA 
interactions (compare Figs. 4B and 5A). One nucleotide reflects a direct interaction with the 
50S subunit and forms part of the B2C inter-subunit bridge (Fig. 5A, purple sphere).34 The 
pattern is again distinctive in the 3' major and minor domains. Of the 47 nucleotides that 
decrease in reactivity in the presence of rifampicin and likely report RNA-protein 
interactions, 66% (31/47) are located in the 3′ major subunit (Fig. 5A, yellow spheres). In 
addition, six nucleotides which decreased in reactivity in the 3’ minor domain reflect direct 
interactions with the 50S subunit (Fig. 5A, purple spheres). Of these six nucleotides, five 
form the B5 and B6 inter-subunit bridges.34.
In sum, the numbers of rRNA nucleotides with differential reactivity by SHAPE in the 
absence and presence of rifampicin increase in the 5' to 3' direction. These changes show a 
striking structural polarity reflecting the assembly of the ribosome and begin predominantly 
with intra-domain RNA-RNA interactions (5' domain), followed by inter-domain RNA-RNA 
interactions (central domain), then intra-subunit (30S) RNA-protein interactions (3' major 
domain), and finally inter-subunit interactions (3' minor domain).
 The predominant 30S state in growing bacteria is a late assembly intermediate
This and other recent work1 emphasizes that the cellular environment has large and poorly 
understood effects on RNA structure. For completely synthesized transcripts, the highly 
crowded environment in an E. coli cell appears to stabilize and favor more organized higher-
order RNA structure.1 This effect undoubtedly influences bacterial ribosome structure, as 
well. Here we observed an additional effect of the cellular environment: the effect of on-
going co-transcriptional assembly and structural biogenesis. During the snapshot taken 
during our in-cell probing experiment, the steady-state structure of 16S rRNA in healthy 
growing E. coli cells is heavily influenced by 16S rRNA that has not yet been fully 
assembled into mature 30S subunits.
Fourteen helical structures do not form stably in the intermediate state that predominates in 
rapidly growing cells (Fig. 2). Current evidence strongly suggests that folding of these 
helices coincides with a critical, late-stage, rate-determining step in ribosome assembly. 
First, eight of these helices (H2, H3, H12, H28, H34, H36, H38 and H44) are also unfolded 
when ribosomes are deproteinized.18 These unfolded structures thus comprise 
thermodynamically preferred RNA states. Second, chemical modification of seven of these 
same helices (H2, H12, H28, H31, H34, H36 and H44) interferes with ribosome assembly.35 
Third, these helices are similar to those that are either improperly folded or interact with 
protein partners that are missing in immature 30S subunits created by deleting the ribosome 
late-assembly factors RbfA and RimM.4,36 Finally, six of the eight proteins that bind directly 
to the unfolded helices were defined as late-binding tertiary proteins in the original Nomura 
maps31 and have recently been shown to bind during late stages of ribosome assembly in 
vivo.3 (Fig. 5B and 5C, in yellow). Thus, although there are likely to be multiple species 
present, a significant fraction of the still-maturing interactions detected in the 2-min SHAPE 
snapshot correspond to events that occur at late stages in 30S subunit assembly.
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 A molecular strut model for ribosomal assembly factors
The 14 incompletely folded helices, seven late-assembly proteins, and S4 form a C-shaped 
motif spanning the 5' and 3' domains of the 16S rRNA (Fig. 6). This region surrounds the 
mRNA binding channel, is important for tRNA binding and codon-anticodon decoding, and 
must be properly folded and arranged for ribosome function.37–39 Three factors, RbfA, 
RimM, and Era, have been shown to facilitate late-stage 30S subunit assembly. These three 
assembly factors bind at well-defined but distinct and largely non-overlapping sites, and can, 
in part, suppress deletion of or compensate for each other.6,40 These proteins all bind in the 
concave face of the C-shaped structure formed by the helices and proteins that we have 
shown rearrange in late stages of ribosome assembly (Fig. 6). We interpret the partially 
overlapping functions of these assembly factors in terms of a "molecular strut" model. Late 
stage assembly involves large-scale RNA structural rearrangements (Fig. 3) and protein 
assembly events (Fig. 5) that we hypothesize require, or are facilitated by, partial pre-
organization of the C-shaped interaction network. In this model, assembly factors function in 
part to promote organization the C-shaped mRNA channel area by binding in the cleft. An 
individual factor could therefore compensate for contributions by another assembly factor, as 
long as this structural organization function were provided.
 Summary
In-cell SHAPE probing of growing E. coli cells showed that ribosomal assembly 
intermediates accumulate and may even predominate in rapidly growing cells. The SHAPE-
detected transcriptional pulse-chase approach outlined in this work is both straightforward 
and information-rich and will likely find broad utility in understanding the steady-state RNA 
dynamics of other RNAs and RNA-protein complexes, and in other cell types.
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Figure 1. In vivo SHAPE of 16S ribosomal RNA
(A) Schematic for using 1M7 to obtain ~2 min structural snapshots in vivo. (B) Pseudo-first 
order hydrolysis of 1M7 in Luria Broth (37 °C) at pH 7.0, corresponding to the mid-log 
phase of cell growth. This panel was adapted from prior work.1 (C) Electropherogram 
resulting from in-cell SHAPE probing of 16S rRNA. Region shown lies in the central 
domain. Reactions performed in the presence and absence of 1M7 are indicated by blue and 
green, respectively; dideoxy sequencing (ddC) trace is black. (D) Histogram of normalized 
SHAPE reactivities.23
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Figure 2. In vivo SHAPE reactivities superimposed on the E. coli 16S secondary structure model 
determined by comparative sequence analysis
Regions in which SHAPE data are consistent with the phylogenetically26 and 
crystallographically25 supported structures are shaded in gray. Helices where SHAPE data 
are not consistent with the secondary structure model are boxed. Alternate base pair pairs, 
supported by SHAPE probing, are emphasized with dark blue lines.
McGinnis and Weeks Page 13













Figure 3. In vivo SHAPE reactivities for the 16S rRNA after transcription inhibition
Transcription was halted by treatment with rifampicin.28 Nucleotides with significant 
decreases or increases in SHAPE reactivity (≥ 0.3) due to transcription arrest are highlighted 
in blue and orange, respectively. Boxed helices are those shown in Fig. 2.
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Figure 4. Transcription-dependent differences in SHAPE reactivity in the 16S rRNA
(A) Positions with significant differences in SHAPE reactivity in the absence and presence 
of rifampicin. The number of nucleotides with significant differences in reactivity when the 
two conditions were compared were summed in 51-nucleotide windows. Domain junctions 
are emphasized with vertical dashed lines. (B) All nucleotides with significant differences in 
SHAPE reactivity in the absence and presence of rifampicin visualized on the structure of 
the 16S rRNA (3i1m).25 Ribosomal domains are expanded along a horizontal axis 
corresponding to the 5' to 3' polarity of their synthesis during transcription (dashed line). 
Inset shows complete ribosomal RNA. Number and percentage of nucleotides in each 16S 
rRNA domain whose SHAPE reactivities changed relative to the number of nucleotides in 
the domain are given.
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Figure 5. RNA-RNA, RNA-protein, and RNA-domain interactions detected by comparison of 
SHAPE reactivities in the presence and absence of transcription
(A) The 2'-OH groups that show significant changes in SHAPE reactivity upon transcription 
inhibition and that are located at the surface of each ribosomal RNA domain are highlighted 
with spheres. Interacting groups, as inferred from the high-resolution structure, are 
emphasized by the coloring scheme shown at right. Domains are expanded in the same left-
to-right orientation as in the standard view the intact 16S rRNA (see inset). Interactions with 
bridges to the 50S subunit are labeled. (B) Relationship between 16S rRNA helices that do 
not form stably in rapidly growing cells in the presence of transcription (magenta and cyan, 
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as also shown in Fig. 2) juxtaposed with proteins in direct contact with these helices. (C) 
Positions of ribosomal proteins in direct contact with helices that change structure during 
assembly in a ribosome protein assembly map; yellow circles emphasize tertiary binding 
proteins.31 The four rows of proteins indicate early to late assembly intermediates, as 
measured by size of 30S-containing complexes in vivo.3
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Figure 6. Positions of misfolded helices and late-binding proteins relative to late-stage ribosome 
assembly factors
Positions of RbfA, RimM and Era are as defined by electron microscopy.36,41,42 Misfolded 
helices are in cyan and purple (see Fig. 2) and the proteins that directly contact these RNA 
elements are shown as gray surfaces.
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